A 22-year-old medical student was shocked to learn during an in-class ultrasound demonstration that there was a large kidney ...

Iron overload is prevalent among adults with sickle cell disease (SCD), according to a study presented at the annual meeting ...

Older people with a history of chronic kidney disease or conditions affecting blood flow to the brain such as stroke face ...

Helminthosis poses a greater global disease burden than malaria and tuberculosis, leading to impaired growth, infertility, and even death in infected individuals. The immuno-pathology of these ...

Two years after this, Sakaguchi was able to link these discoveries. He proved that the Foxp3 gene governs the development of ...

Standard-of-care treatment with Janus kinase inhibitor monotherapy improves splenomegaly and symptom burden but provides ...

New trials reveal INCA033989 shows promise for treating CALR exon 9-mutated myelofibrosis, demonstrating efficacy and tolerability in patients.

Cellarity, a clinical-stage biotechnology company developing Cell State-Correcting therapies through integrated multi-omics and AI modeling, today announced the presentation of new preclinical data on ...

The 2025 meeting of the American Society of Hematology features some of the newest developments in blood cancers and rare ...

Early ASH 2025 data shows Incyte's INCA033989 delivers spleen, anemia and symptom improvements in mutCALR myelofibrosis.